氯氮平在诱发难治性精神分裂患者中肺栓塞的研究进展

Research progress of clozapine in inducing pulmonary embolism in patients with refractory schizophrenia

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2021, 48(4)
作者
作者单位

深圳市康宁医院 ;

摘要
药物源性心血管系统并发症是导致精神疾病患者死亡的主要原因,典型或非典型抗精神病药物均可诱发或导致其的发生。氯氮平作为第二代抗精神病药物,在难治性精神病、阴性症状为主型精神分裂症的治疗中发挥着巨大的作用。已有研究表明氯氮平有诱发或促进深静脉血栓形成及肺栓塞发生危险性。这提醒临床医师在对难治性精神病患者进行药物治疗时,要提高对氯氮平等二代抗精神病药物可能导致肺栓塞的重视,纠正错误用药习惯,避免危险因素,降低相关严重后果的发生。本文拟对氯氮平与肺栓塞的相关性展开讨论,旨在梳理氯氮平在诱发难治性精神病患者中肺栓塞发生的原因及危险因素,并提出几点针对性预防措施的建设性意见。
Abstract
Drug induced cardiovascular complications are the main cause of death in patients with mental illness. Typical or atypical antipsychotics can induce or lead to their occurrence. Clozapine, as the second generation of antipsychotics, plays an important role in the treatment of refractory psychosis and schizophrenia with negative symptoms. Previous studies have shown that clozapine can induce or promote deep vein thrombosis and pulmonary embolism. This reminds clinicians to pay more attention to the possibility of pulmonary embolism caused by the second generation antipsychotics, correct the wrong medication habits, avoid the risk factors and reduce the occurrence of related serious consequences. This article intends to discuss the correlation between clozapine and pulmonary embolism, aiming to sort out the causes and risk factors of clozapine induced pulmonary embolism in patients with refractory psychosis, and put forward some constructive suggestions on targeted preventive measures.
关键词
氯氮平;难治性精神病;肺栓塞
KeyWord
Clozapine; refractory psychosis; pulmonary embolism
基金项目
页码 604-606
  • 参考文献
  • 相关文献
  • 引用本文

孙李晴*,江依勇,蔡溢. 氯氮平在诱发难治性精神分裂患者中肺栓塞的研究进展 [J]. 国际精神病学杂志. 2021; 48; (4). 604 - 606.

  • 文献评论

相关学者

相关机构